Hoshino J, Frahm J, Kröger H
Cancer Lett. 1987 Jun;35(3):245-51. doi: 10.1016/0304-3835(87)90126-1.
A single administration of 5-azacytidine (5-ACR) to partially hepatectomized rats 24 h following operation resulted in a dose-dependent reduction of nuclear ADP-ribosyltransferase (ADPRT) activity in the liver, when assayed after the nuclei were isolated 22 h after injection. No such a suppression by 5-ACR was observed in the liver of intact rats. Cytidine, a known agent which prevents the incorporation of 5-ACR into DNA, abolished the suppression of ADPRT, when it was given in combination with 5-ACR. The 5-ACR suppressed nuclei from regenerating liver showed no decreased DNA methylating activity, as estimated from the rate of radiolabel transfer from [methyl-3H]SAM to the bulk DNA. The methylation of nuclear RNA and protein was markedly reduced. These results suggest that the incorporation of 5-ACR into nucleic acids inactivates chromatin-bound ADPRT without inhibition of DNA methylation.
在部分肝切除的大鼠术后24小时单次给予5-氮杂胞苷(5-ACR),在注射后22小时分离细胞核进行检测时,肝脏中的核ADP-核糖基转移酶(ADPRT)活性呈剂量依赖性降低。在完整大鼠的肝脏中未观察到5-ACR的这种抑制作用。胞苷是一种已知的可阻止5-ACR掺入DNA的物质,当它与5-ACR联合给药时,可消除对ADPRT的抑制作用。从[甲基-3H]SAM向总DNA的放射性标记转移速率估计,5-ACR抑制的再生肝细胞核的DNA甲基化活性没有降低。核RNA和蛋白质的甲基化明显减少。这些结果表明,5-ACR掺入核酸会使染色质结合的ADPRT失活,而不抑制DNA甲基化。